Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Notch3 and HEY-1 as prognostic biomarkers in pancreatic adenocarcinoma.

Mann CD, Bastianpillai C, Neal CP, Masood MM, Jones DJ, Teichert F, Singh R, Karpova E, Berry DP, Manson MM.

PLoS One. 2012;7(12):e51119. doi: 10.1371/journal.pone.0051119. Epub 2012 Dec 4.

2.

Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.

Ahn S, Hyeon J, Park CK.

Hepatobiliary Pancreat Dis Int. 2013 Jun;12(3):286-94.

3.

Nuclear Notch3 expression is associated with tumor recurrence in patients with stage II and III colorectal cancer.

Ozawa T, Kazama S, Akiyoshi T, Murono K, Yoneyama S, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Nozawa H, Kanazawa T, Yamaguchi H, Ishihara S, Sunami E, Kitayama J, Morikawa T, Fukayama M, Watanabe T.

Ann Surg Oncol. 2014 Aug;21(8):2650-8. doi: 10.1245/s10434-014-3659-9. Epub 2014 Apr 12.

PMID:
24728738
4.

Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis.

Yuan X, Wu H, Xu H, Han N, Chu Q, Yu S, Chen Y, Wu K.

Sci Rep. 2015 May 21;5:10338. doi: 10.1038/srep10338.

5.

Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression.

Kang H, An HJ, Song JY, Kim TH, Heo JH, Ahn DH, Kim G.

Histopathology. 2012 Oct;61(4):576-86. doi: 10.1111/j.1365-2559.2012.04274.x.

PMID:
22691042
6.

Prognostic significance of epidermal growth factor receptor overexpression in pancreas cancer and nodal metastasis.

Perini MV, Montagnini AL, Coudry R, Patzina R, Penteado S, Abdo EE, Diniz A, Jukemura J, da Cunha JE.

ANZ J Surg. 2015 Mar;85(3):174-8. doi: 10.1111/ans.12399. Epub 2013 Sep 25.

PMID:
24112413
7.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
8.
9.

Notch3 signaling is associated with MUC5AC expression and favorable prognosis in patients with small intestinal adenocarcinomas.

Eom DW, Hong SM, Kim J, Kim G, Bae YK, Jang KT, Yu E.

Pathol Res Pract. 2014 Aug;210(8):501-7. doi: 10.1016/j.prp.2014.04.003. Epub 2014 Apr 18.

PMID:
24810798
10.

Prognostic significance of PINCH signalling in human pancreatic ductal adenocarcinoma.

Scaife CL, Shea J, Emerson L, Boucher K, Firpo MA, Beckerle MC, Mulvihill SJ.

HPB (Oxford). 2010 Jun;12(5):352-8. doi: 10.1111/j.1477-2574.2010.00177.x.

11.

NOTCH1, NOTCH3, NOTCH4, and JAG2 protein levels in human endometrial cancer.

Sasnauskienė A, Jonušienė V, Krikštaponienė A, Butkytė S, Dabkevičienė D, Kanopienė D, Kazbarienė B, Didžiapetrienė J.

Medicina (Kaunas). 2014;50(1):14-8. doi: 10.1016/j.medici.2014.05.002. Epub 2014 Jun 6.

12.

High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.

Chen HT, Cai QC, Zheng JM, Man XH, Jiang H, Song B, Jin G, Zhu W, Li ZS.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S464-74. doi: 10.1245/s10434-011-1968-9. Epub 2011 Aug 6.

PMID:
21822553
13.

Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma.

Gramantieri L, Giovannini C, Lanzi A, Chieco P, Ravaioli M, Venturi A, Grazi GL, Bolondi L.

Liver Int. 2007 Sep;27(7):997-1007.

PMID:
17696940
14.

The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.

La Torre M, Nigri G, Cavallini M, Mercantini P, Ziparo V, Ramacciato G.

Ann Surg Oncol. 2012 Sep;19(9):2917-23. doi: 10.1245/s10434-012-2348-9. Epub 2012 Apr 10.

PMID:
22488099
15.

Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.

Fong D, Steurer M, Obrist P, Barbieri V, Margreiter R, Amberger A, Laimer K, Gastl G, Tzankov A, Spizzo G.

J Clin Pathol. 2008 Jan;61(1):31-5. Epub 2006 Jun 14.

PMID:
16775119
16.

Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma.

Denley SM, Jamieson NB, McCall P, Oien KA, Morton JP, Carter CR, Edwards J, McKay CJ.

J Gastrointest Surg. 2013 May;17(5):887-98. doi: 10.1007/s11605-013-2168-7. Epub 2013 Feb 23.

PMID:
23435739
17.

Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma.

Niedergethmann M, Rexin M, Hildenbrand R, Knob S, Sturm JW, Richter A, Post S.

Am J Surg Pathol. 2002 Dec;26(12):1578-87.

PMID:
12459624
18.

Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.

Guo S, Jing W, Hu X, Zhou X, Liu L, Zhu M, Yin F, Chen R, Zhao J, Guo Y.

Int J Cancer. 2014 Mar 15;134(6):1369-78. doi: 10.1002/ijc.28471. Epub 2013 Oct 3.

19.

Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma.

Jung SG, Kwon YD, Song JA, Back MJ, Lee SY, Lee C, Hwang YY, An HJ.

Cancer Sci. 2010 Sep;101(9):1977-83. doi: 10.1111/j.1349-7006.2010.01641.x.

20.

Targeting notch pathway enhances rapamycin antitumor activity in pancreas cancers through PTEN phosphorylation.

Vo K, Amarasinghe B, Washington K, Gonzalez A, Berlin J, Dang TP.

Mol Cancer. 2011 Nov 10;10:138. doi: 10.1186/1476-4598-10-138.

Supplemental Content

Support Center